JRARX | VIGIX | JRARX / VIGIX | |
Total Expense Ratio | 1.32 | 0.04 | 3,300% |
Annual Report Gross Expense Ratio | 1.38 | 0.04 | 3,450% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | 16.108 | 16.593 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 28.6B | 342B | 8% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 14.06 | 22.80 | 62% |
Returns for 3 years | 108.35 | 119.37 | 91% |
Returns for 5 years | 53.90 | 102.23 | 53% |
Returns for 10 years | N/A | 352.62 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LRGC | 76.82 | 0.33 | +0.44% |
AB US Large Cap Strategic Equities ETF | |||
SHYM | 22.28 | 0.03 | +0.13% |
iShares Short Duration HY Muni Act ETF | |||
BOXX | 114.06 | 0.03 | +0.03% |
Alpha Architect 1-3 Month Box ETF | |||
BBP | 72.05 | -0.09 | -0.12% |
Virtus LifeSci Biotech Products ETF | |||
GDMA | 38.84 | -0.37 | -0.93% |
Gadsden Dynamic Multi-Asset ETF |